Nonclinical data on Provectus PV-10 oncology drug presented at 27th SITC

[News]

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented nonclinical data on PV-10 at the Society for Immunotherapy of Cancer (SITC) 27th Annual Meeting on October 26 and 27, 2012 in North Bethesda, MD.

More... (http://www.news-medical.net/news/20121029/Nonclinical-data-on-Provectus-PV-10-oncology-drug-presented-at-27th-SITC.aspx)